Alex G. Howarth

Insider Reports History

Entity
Individual
Location
C/O Akcea Therapeutics, Inc., 22 Boston Wharf Road, 9 Th Floor, Boston, MA
Signature
/s/ Brian J. Lynch**
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alex G. Howarth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. Chief Financial Officer Common Stock 18.7K $4.57M $243.92 Jan 23, 2024 Direct
MADRIGAL PHARMACEUTICALS, INC. Chief Financial Officer Market Stock Unit 4.8K $1.17M $243.92 Jan 23, 2024 Direct
MADRIGAL PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 7.24K Jan 23, 2024 Direct

Insider Reports Filed by Alex G. Howarth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 23, 2024 3 $0 4 Jan 25, 2024 Chief Financial Officer
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 16, 2024 1 -$260K 4 Jan 18, 2024 Chief Financial Officer
MDGL MADRIGAL PHARMACEUTICALS, INC. Jan 16, 2023 1 $0 4 Jan 18, 2023 Chief Financial Officer
MDGL MADRIGAL PHARMACEUTICALS, INC. Feb 22, 2022 1 $0 4 Feb 24, 2022 Chief Financial Officer
MDGL MADRIGAL PHARMACEUTICALS, INC. Nov 1, 2021 1 $0 4 Nov 3, 2021 Chief Financial Officer
MDGL MADRIGAL PHARMACEUTICALS, INC. May 17, 2021 1 $0 4 May 19, 2021 Chief Financial Officer
MDGL MADRIGAL PHARMACEUTICALS, INC. May 17, 2021 0 $0 3 May 19, 2021 Chief Financial Officer